Emkay Global Financial Services is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 265 in its April 1, 2011 research report.

Sell Aurobindo Pharma: Aditya Birla Money

Aditya Birla Money is bearish on Aurobindo Pharma and has recommended sell rating on the stock with a target of Rs 165-160 in its March 29, 2011 research report.

Buy Aurobindo Pharma; tgt of Rs 312: Anand Rathi Securities

Anand Rathi Securities is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 312 in its February 24, 2011 research report.

Aurobindo Pharma a market performer; tgt of Rs 235: Karvy

Karvy Stock Broking is bullish on Aurobindo Pharma and has recommended a market performer rating on the stock with a target of Rs 235 in its February 24, 2011 research report.

Buy Aurobindo Pharma; target of Rs 1415: Angel Broking

Angel Broking is bullish on Aurobindo Pharma (APL) and has recommended buy rating on the stock with a target of Rs 1415 in its February 8, 2011 research report.

Buy Aurobindo Pharma; tgt of Rs 1620: Karvy Stock Broking

Karvy Stock Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 1620 in its February 7, 2011 research report.

Buy Aurobindo Pharma; target of Rs 1560: Anand Rathi Sec

Anand Rathi Securities is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 1560 in its January 11, 2011 research report.

Hold Aurobindo Pharma; target of Rs 1352: KRChoksey

KRChoksey has maintained hold rating on Aurobindo Pharma with a target of Rs 1352 in its January 10, 2011 research report.

Buy Aurobindo Pharma; tgt of Rs 1645: Karvy Stock Broking

Karvy Stock Broking is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 1645 in its January 11, 2011 research report.

Short Aurobindo Pharma; tgt of Rs 1220: Aditya Birla Money

Aditya Birla Money is bearish on Aurobindo Pharma and has recommended short rating on the stock with a target of Rs 1220 in its January 10, 2011 research report.

Buy Aurobindo Pharma; tgt of Rs 1630: Fairwealth Securities

Fairwealth Securities is bullish on Aurobindo Pharma and has recommended buy rating on the stock with a target of Rs 1630 in its January 6, 2011 research report.